← Leaderboards
Steven L Armentrout
Parabon Nanolabs, Inc.
$3,616,280
Attributed
$3,616,280
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2011–24$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$3,616,280 · 6
By mechanism
R44$1,929,269 · 1
R43$1,069,226 · 3
R41$400,000 · 1
U43$217,785 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Design”
- Lawrence Corey · Fred Hutchinson Cancer Center$736,542,541
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$460,267,569
- Jeffrey P Krischer · University Of South Florida$427,700,530
- David R. Weir · University Of Michigan At Ann Arbor$385,316,144
Research focus
DesignSmall Business Innovation Research GrantCell LineCellsNanostructuresAffectEngineeringNanocarrierAlzheimer&AposIn VitroPersonsPerformanceFaceVariantLabelCommercializationIn VivoLeadImagePeptidesProductionConfocal MicroscopyMonitorShapes
Grant awards (10)
Parametric design software for nanostructured CRISPR payloads$49,930
R43 · FY2024 · GM · contact PI
A nanoengineering platform for programmable gene editing therapies against rare diseases$325,000
R43 · FY2023 · GM · contact PI
Parametric design software for nanostructured CRISPR payloads$299,999
R43 · FY2023 · GM · contact PI
Smartphone phenotype collection for diagnostic screening of mild cognitive impairment$742,644
R44 · FY2022 · AG · contact PI
A multitargeted nanocarrier inhibitor of undruggable transcription factors for treating castration resistant prostate cancer$149,491
R41 · FY2022 · CA · contact PI
Smartphone phenotype collection for diagnostic screening of mild cognitive impairment$1,186,625
R44 · FY2021 · AG · contact PI
A multitargeted nanocarrier inhibitor of undruggable transcription factors for treating castration resistant prostate cancer$250,509
R41 · FY2021 · CA · contact PI
Smartphone phenotype collection for diagnostic screening of mild cognitive impairment$394,297
R43 · FY2018 · AG · contact PI
Mixed-Ligand Targeting of a Nano-Pharmaceutical Against GBM Stem Cells$43,019
U43 · FY2012 · CA · contact PI
Mixed-Ligand Targeting of a Nano-Pharmaceutical Against GBM Stem Cells$174,766
U43 · FY2011 · CA · contact PI